Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $97,632 - $149,616
7,200 Added 57.14%
19,800 $285,000
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $178,668 - $281,106
12,600 New
12,600 $271,000
Q1 2023

May 15, 2023

BUY
$30.17 - $41.11 $168,952 - $230,216
5,600 New
5,600 $202,000
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $430,995 - $562,118
10,600 New
10,600 $494,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.